Back to all Programs

Past Event

Related Materials

Past Event

International Workshop on NASH Biomarkers 2017

Viral Hepatitis and Liver Disease

Opening lecture: A pathologist, a radiologist and a hepatologist walked into a bar | Brent Neuschwander-Tetri, MD

Viral Hepatitis and Liver Disease

Innovation in histological assessment of NASH | Pierre Bedossa, MD, PhD

Viral Hepatitis and Liver Disease

Collaboration in action - Foundation for the National Institutes of Health | Roberto Calle, MD, FACE, FACP

Viral Hepatitis and Liver Disease

Collaboration in action - Innovative Medicines Initiative | Quentin Anstee, BSc, MB BS, PhD, MRCP(UK), FRCP

Viral Hepatitis and Liver Disease

Role of genetic assessments | Quentin Anstee, BSc, MB BS, PhD, MRCP(UK), FRCP

Viral Hepatitis and Liver Disease

Circulating nucleic acids and combination panels | Sven Francque, MD, PhD

Viral Hepatitis and Liver Disease

MRI; what can it deliver | Claude Sirlin, MD

Viral Hepatitis and Liver Disease

Transient elastography & other techniques | Raj Vuppalanchi, MBBS

Viral Hepatitis and Liver Disease

Breath tests | Shadab Siddiqui, MD

Viral Hepatitis and Liver Disease

Principles of kinetic measures | Greg Everson, MD, FACP

Viral Hepatitis and Liver Disease

Big data vs. the individual liver - regulatory perspective | Robert Schuck, PharmD, PhD

Viral Hepatitis and Liver Disease

Integrated assessment of diabetes, cardiovascular and liver risks and its potential application in the clinical management of NAFLD | Arun Sanyal, MD, MBBS

Viral Hepatitis and Liver Disease

Navigating NASH biomarkers: From discovery to clinical practice | John Sninsky, PhD